Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-25T18:31:38.319Z Has data issue: false hasContentIssue false
  • English
  • Français

Can Antidepressants Act as Potential Pro-neoplastic Agents in Patients with Neurotrophic Factor-Related Cancers?

Published online by Cambridge University Press:  07 November 2014

Yung-Tian A. Gau ,
Chen-Jee Hong  and
Shih-Jen Tsai
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Communique
Information
CNS Spectrums , Volume 13 , Issue 10 , October 2008 , pp. 849 - 850
Copyright
Copyright © Cambridge University Press 2008

References

REFERENCES

1.Massie, MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;32:57–71.CrossRefGoogle Scholar
2.Chaturvedi, S, Maguire, P, Hopwood, P. Antidepressant medications in cancer patients. Psycho-Oncology. 1994;3:57–60.CrossRefGoogle Scholar
3.Dias, BG, Banerjee, SB, Duman, RS, Vaidya, VA. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology. 2003;5:553–563.CrossRefGoogle Scholar
4.Nibuya, M, Morinobu, S, Duman, RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 1995;15:7539–7547.CrossRefGoogle ScholarPubMed
5.Ivy, AS, Rodriguez, FG, Garcia, C, Chen, MJ, Russo-Neustadt, AA. Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant. Pharmacol Biochem Behav. 2003;75:81–88.CrossRefGoogle ScholarPubMed
6.Coppell, AL, Pei, Q, Zetterstrom, TSC. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology. 2003;44:903–910.CrossRefGoogle ScholarPubMed
7.Saarelainen, T, Hendolin, P, Lucas, G, et al.Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant induced behavioral effects. J Neurosci. 2003;23:349–357.CrossRefGoogle ScholarPubMed
8.Chen, B, Dowlatshahi, D, MacQueen, GM, Wang, JF, Young, LT. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry. 2001;50:260–265.CrossRefGoogle ScholarPubMed
9.Sartor, L, Negro, A, Barletta, E, Mugnai, G, Garbisa, S. Modulation of proteolytic potential and differentiation by CNTF and BDNF in two mouse neuroblastoma clones: relation to invasion. Clin Exp Metastasis. 2002;19:709–716.CrossRefGoogle Scholar
10.Middlemas, DS, Kihl, BK, Moody, NM. Brain derived neurotrophic factor protects human neuroblastoma cells from DNA damaging agents. J Neurooncol. 1999;45:27–36.CrossRefGoogle ScholarPubMed
11.Jaboin, J, Kim, CJ, Kaplan, DR, Thiele, CJ. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway. Cancer Res. 2002;62:6756–6763.Google ScholarPubMed
12.Warner-Schmidt, JL, Duman, RS. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci U S A. 2007;104:4647–4652.CrossRefGoogle ScholarPubMed
13.McMahon, G. VEGF receptor signaling in tumor angiogenesis. Oncologist. 2000;5(suppl 1):3–10.CrossRefGoogle ScholarPubMed
14.Brandes, LJ, Arron, RJ, Bogdanovic, RP, et al.Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res. 1992;52:3796–3800.Google ScholarPubMed